Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23219Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kyritsis, A. P. | en |
| dc.contributor.author | Williams, E. C. | en |
| dc.contributor.author | Schutta, H. S. | en |
| dc.date.accessioned | 2015-11-24T19:31:10Z | - |
| dc.date.available | 2015-11-24T19:31:10Z | - |
| dc.identifier.issn | 0039-2499 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23219 | - |
| dc.rights | Default Licence | - |
| dc.subject | *Cerebral Veins | en |
| dc.subject | Female | en |
| dc.subject | Heparin/*adverse effects/therapeutic use | en |
| dc.subject | Humans | en |
| dc.subject | Middle Aged | en |
| dc.subject | Platelet Aggregation/drug effects | en |
| dc.subject | Polycythemia Vera/*complications | en |
| dc.subject | Thrombophlebitis/complications/*therapy | en |
| dc.subject | Thrombosis/blood/*chemically induced | en |
| dc.title | Cerebral venous thrombosis due to heparin-induced thrombocytopenia | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/2219218 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1990 | - |
| heal.abstract | A patient with polycythemia vera who was treated with heparin for superficial septic thrombophlebitis developed heparin-induced thrombocytopenia and cerebral venous thrombosis with superior sagittal sinus occlusion 11 days after the institution of heparin therapy. We suggest that the severe thrombotic response to the heparin-induced platelet disorder in this patient occurred because the polycythemia vera and the purulent infection enhanced the thrombophilia caused by heparin-induced thrombocytopenia. This condition can be avoided in most instances if heparin is used for no longer than 5 days. | en |
| heal.journalName | Stroke | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
